Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


20.05.2024

1 Am J Pathol
1 Am J Respir Crit Care Med
1 Ann Surg Oncol
1 Ann Thorac Surg
2 Arch Bronconeumol
2 BMC Cancer
3 Br J Cancer
1 Cancer
1 Cancer Cell
2 Cancer Lett
1 Cancer Res
1 Cancer Sci
3 Clin Lung Cancer
2 Eur J Cardiothorac Surg
1 Int J Cancer
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Clin Oncol
2 J Thorac Cardiovasc Surg
2 JAMA Oncol
2 Lung Cancer
1 Lung Cancer (Auckl)
2 N Engl J Med
2 Nat Med
6 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Pathol

  1. INGALE K, Hong SH, Bell JSK, Rizvi A, et al
    Prediction of MET Overexpression in Lung Adenocarcinoma from Hematoxylin and Eosin Images.
    Am J Pathol. 2024;194:1020-1032.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  2. SAYADI A, Debray MP, Mordant P, Dupin C, et al
    Diffuse Pulmonary Neuroendocrine Cell Hyperplasia with Parietal Pleural Involvement.
    Am J Respir Crit Care Med. 2024;209:1258-1260.
    PubMed        


    Ann Surg Oncol

  3. ISHIDA M, Mimae T, Kamigaichi A, Kawamoto N, et al
    The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer.
    Ann Surg Oncol. 2024 May 13. doi: 10.1245/s10434-024-15126.
    PubMed         Abstract available


    Ann Thorac Surg

  4. RUSCH VW
    Wedge Resection Versus Segmentectomy for Clinical Stage IA Non-small Cell Lung Cancer: Are They Truly Oncologically Equivalent?
    Ann Thorac Surg. 2024 May 9:S0003-4975(24)00359.
    PubMed        


    Arch Bronconeumol

  5. ASHIQUE S, Mishra N, Garg A, Kumar N, et al
    A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis.
    Arch Bronconeumol. 2024 May 6:S0300-2896(24)00144.
    PubMed         Abstract available

  6. PORCEL JM, Pont M, Sorolla A
    CRISPR Technology in Lung Diseases: The Example of Lung Cancer and Cystic Fibrosis.
    Arch Bronconeumol. 2024 Apr 30:S0300-2896(24)00128.
    PubMed        


    BMC Cancer

  7. GU C, Teng X, Sun X, Liu J, et al
    Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma.
    BMC Cancer. 2024;24:585.
    PubMed         Abstract available

  8. PANG H, Dai L, Chen L, Chen X, et al
    Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysis.
    BMC Cancer. 2024;24:583.
    PubMed         Abstract available


    Br J Cancer

  9. MALAPELLE U, Leighl N, Addeo A, Hershkovitz D, et al
    Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
    Br J Cancer. 2024 May 15. doi: 10.1038/s41416-024-02709.
    PubMed         Abstract available

  10. JEONG H, Koh J, Kim S, Song SG, et al
    Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer.
    Br J Cancer. 2024 May 10. doi: 10.1038/s41416-024-02698.
    PubMed         Abstract available

  11. KATO T, Yang JC, Ahn MJ, Sakai H, et al
    Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
    Br J Cancer. 2024;130:1679-1686.
    PubMed         Abstract available


    Cancer

  12. BYRD DA, Zouiouich S, Karwa S, Li XS, et al
    Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
    Cancer. 2024 Jan 29. doi: 10.1002/cncr.35219.
    PubMed         Abstract available


    Cancer Cell

  13. LIU SY, Feng WN, Wu YL
    Immunotherapy in resectable NSCLC: Answering the question or questioning the answer?
    Cancer Cell. 2024;42:727-731.
    PubMed         Abstract available


    Cancer Lett

  14. ZHENG L, Shen J, Chen Y, Lin J, et al
    FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2.
    Cancer Lett. 2024;591:216848.
    PubMed         Abstract available

  15. JIANG Y, Li S, Ramesh R
    Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment.
    Cancer Lett. 2024 May 10:216932. doi: 10.1016/j.canlet.2024.216932.
    PubMed        


    Cancer Res

  16. RAINERO E
    Overcoming Nutrient Stress: Integrin alphavbeta3-Driven Metabolic Adaptation Supports Tumor Initiation.
    Cancer Res. 2024;84:1543-1545.
    PubMed         Abstract available


    Cancer Sci

  17. DUCH P, Diaz-Valdivia N, Gabasa M, Ikemori R, et al
    Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma.
    Cancer Sci. 2024;115:1505-1519.
    PubMed         Abstract available


    Clin Lung Cancer

  18. TILL BM, Grenda T, Tidwell T, Wickes B, et al
    Brief Report: Nonmalignant Surgical Resection Among Individuals with Screening-Detected Versus Incidental Lung Nodules.
    Clin Lung Cancer. 2024;25:e129-e132.
    PubMed        

  19. WONG LY, Choudhary S, Kapula N, Lin M, et al
    Barriers to Completing Low Dose Computed Tomography Scan for Lung Cancer Screening.
    Clin Lung Cancer. 2024 Apr 27:S1525-7304(24)00070.
    PubMed         Abstract available

  20. ZHANG W, Tian S, Li X, Chen Y, et al
    ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature.
    Clin Lung Cancer. 2024;25:215-224.
    PubMed         Abstract available


    Eur J Cardiothorac Surg

  21. BRUNELLI A, Tariq J, Mittal A, Lodhia J, et al
    Self-reported dyspnoea and shortness of breathing deterioration in long-term survivors after segmentectomy or lobectomy for early-stage lung cancer.
    Eur J Cardiothorac Surg. 2024 May 15:ezae200. doi: 10.1093.
    PubMed         Abstract available

  22. PROVOOST AL, Bouckaert A, Vanluyten C, Barbarossa A, et al
    Aerostasis to limit air leak following extended pleurectomy-decortication.
    Eur J Cardiothorac Surg. 2024;65:ezae181.
    PubMed         Abstract available


    Int J Cancer

  23. BRATIVNYK A, Ankill J, Helland A, Fleischer T, et al
    Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.
    Int J Cancer. 2024;155:282-297.
    PubMed         Abstract available


    Int J Oncol

  24. TAI F, Zhai R, Ding K, Zhang Y, et al
    Long non?coding RNA lung cancer?associated transcript 1 regulates ferroptosis via microRNA?34a?5p?mediated GTP cyclohydrolase 1 downregulation in lung cancer cells.
    Int J Oncol. 2024;64:64.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  25. CASEY DL, Vogelius IR, Brodin NP, Roberts KB, et al
    Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:640-654.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  26. DANG J, Xu G, Guo G, Zhang H, et al
    Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    J Cancer Res Clin Oncol. 2024;150:255.
    PubMed         Abstract available


    J Clin Oncol

  27. MO DC, Chen L, Wu Y, Huang JF, et al
    PD-L1 Expression and Its Prognostic Value in Different Tumor Specimens in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer.
    J Clin Oncol. 2024 May 16:JCO2400230. doi: 10.1200/JCO.24.00230.
    PubMed        


    J Thorac Cardiovasc Surg

  28. SARNAIK KS, Linden PA, Gasnick A, Bassiri A, et al
    Computational risk model for predicting 2-year malignancy of pulmonary nodules using demographic and radiographic characteristics.
    J Thorac Cardiovasc Surg. 2024;167:1910-1924.
    PubMed         Abstract available


  29. Discussion to: Computational risk model for predicting 2-year malignancy of pulmonary nodules using demographic and radiographic characteristics.
    J Thorac Cardiovasc Surg. 2024;167:1925-1926.
    PubMed        


    JAMA Oncol

  30. SORIN M, Prosty C, Ghaleb L, Nie K, et al
    Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis.
    JAMA Oncol. 2024;10:621-633.
    PubMed         Abstract available

  31. ROLFO C, Russo A
    The Chemoimmunotherapy Revolution in Resectable NSCLC-The Times They Are A-Changin'.
    JAMA Oncol. 2024;10:569-570.
    PubMed        


    Lung Cancer

  32. WANG Z, Li X, Chen J, Hua Y, et al
    The significance of inflammatory markers in prognosticating the effectiveness and safety of immunotherapy in conjunction with chemotherapy during the primary intervention of advanced non-small cell lung carcinoma.
    Lung Cancer. 2024;192:107817.
    PubMed         Abstract available

  33. NADAL E, Rifi N, Kane S, Mbacke S, et al
    Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidence.
    Lung Cancer. 2024;192:107816.
    PubMed         Abstract available


    Lung Cancer (Auckl)

  34. GONZALEZ-CAO M, Cai X, Bracht JWP, Han X, et al
    HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer.
    Lung Cancer (Auckl). 2024;15:55-67.
    PubMed         Abstract available


    N Engl J Med

  35. CASCONE T, Awad MM, Spicer JD, He J, et al
    Perioperative Nivolumab in Resectable Lung Cancer.
    N Engl J Med. 2024;390:1756-1769.
    PubMed         Abstract available

  36. GARASSINO MC, Torri V
    Neoadjuvant or Perioperative Approach in Lung Cancer.
    N Engl J Med. 2024;390:1816-1818.
    PubMed        


    Nat Med

  37. SHIELDS MD, Lovly CM
    Refining neoadjuvant immunotherapy for resectable lung cancer.
    Nat Med. 2024 May 13. doi: 10.1038/s41591-024-03001.
    PubMed        

  38. ZENG Y, Hu CH, Li YZ, Zhou JS, et al
    Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer.
    Nat Med. 2024 May 13. doi: 10.1038/s41591-024-02929.
    PubMed         Abstract available


    PLoS One

  39. THU YM, Suzawa K, Tomida S, Ochi K, et al
    PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer.
    PLoS One. 2024;19:e0300644.
    PubMed         Abstract available

  40. CHANG GC, Shih JY, Yu CJ, Chao HS, et al
    Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.
    PLoS One. 2024;19:e0303046.
    PubMed         Abstract available

  41. LEE ACH, Madariaga MLL, Lee SM, Ferguson MK, et al
    The risk analysis index is an independent predictor of outcomes after lung cancer resection.
    PLoS One. 2024;19:e0303281.
    PubMed         Abstract available

  42. WANG H, Zhu H, Ding L, Yang K, et al
    Attention pyramid pooling network for artificial diagnosis on pulmonary nodules.
    PLoS One. 2024;19:e0302641.
    PubMed         Abstract available

  43. N KACHOUIE N, Deebani W, Shutaywi M, Christiani DC, et al
    Lung cancer clustering by identification of similarities and discrepancies of DNA copy numbers using maximal information coefficient.
    PLoS One. 2024;19:e0301131.
    PubMed         Abstract available


  44. Editorial Note: Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of beta-Catenin Signaling.
    PLoS One. 2024;19:e0303600.
    PubMed        


    Proc Natl Acad Sci U S A

  45. FERRARONE JR, Thomas J, Unni AM, Zheng Y, et al
    Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase.
    Proc Natl Acad Sci U S A. 2024;121:e2403685121.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.